Opening Day: Obesity drug developer BioAge makes Nasdaq debut - InvestingChannel

Opening Day: Obesity drug developer BioAge makes Nasdaq debut

Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. LATEST IPOS AND… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3990033/-Opening-Day-Obesity-drug-developer-BioAge-makes-Nasdaq-debut)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire